Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, August, 2009, Advertising

New pharmaceutical account wins notified to us by the winning agency for the period June 2009 and August 2009 inclusive

New pharmaceutical account wins notified to us by the winning agency for the period June 2009 and August 2009 inclusive:

       

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

AAH (UK)
N/A
Corporate
Euro RSCG Life
Abbott Laboratories/ International Kaletra Virology Grace Agency
Baxter Healthcare Renal Division Home dialysis Renal Life
Boehringer Ingelheim New product launch Women's Health MSA Market Media
Gilead Early treatment project HIV Life
GSK UK
Eumovate and Eumocream
Dermatology
Euro RSCG Life
Johnson & Johnson EMA
Vision care
Ophthalmology
Euro RSCG Life
Merck-Serono Global
N/A
Fertility portfolio
Euro RSCG Life
Mundipharma International
New product
Respiratory
Health 4 Brands
Mundipharma International New product Pain
Health 4 Brands
Novo Nordisk
NovoSeven corporate
Haemophilia
Life
Optegra Eye surgery Ophthalmology Sudler & Hennessey


Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

27th August 2009

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics